32.99MMarket Cap-337P/E (TTM)
1.350High1.150Low1.89MVolume1.200Open1.190Pre Close2.40MTurnover16.11%Turnover RatioLossP/E (Static)25.77MShares12.88052wk High-0.60P/B15.01MFloat Cap0.78052wk Low--Dividend TTM11.72MShs Float12.880Historical High--Div YieldTTM16.81%Amplitude0.780Historical Low1.269Avg Price1Lot Size
NKGEN BIOTECH Stock Forum
📊⚡️📊
NKGen Biotech to Present New Positive SNK01 Clinical Trial Biomarker Data at the 2024 Alzheimer’s Association International Conference
NKGen Biotech (Nasdaq: NKGN) will present new biomarker data on its SNK01 therapy for Alzheimer's disease at the 2024 Alzheimer's Association International Conference.
The poster presentation will showcase SNK01's ability to reduce α-synuclein in Alzheimer's patients, which is significant as α-synuclein correlates with worse cognitiv...
No comment yet